Array BioPharma Inc. (NASDAQ: ARRY) is a biopharmaceutical company focused on the discovery, development and commercialization of targeted small molecule drugs to treat patients afflicted with cancer. Eight registration studies are currently advancing related to seven Array-owned or partnered drugs: binimetinib (MEK162), encorafenib (LGX818), selumetinib (partnered with AstraZeneca), danoprevir (partnered with Roche), ipatasertib (partnered with Genentech), larotrectinib (partnered with Loxo Oncology) and tucatinib (partnered with Cascadian Therapeutics). We have locations in Boulder, CO; Cambridge, MA; and Morrisville, NC.
Company Details
- Employees
- 111
- Founded
- -
- Address
- 3200 Walnut Street, Boulder,co 80301,united States
- Phone
- 303.381.6600
- in****@****rma.com
- Industry
- Pharmaceutical Manufacturing
- NAICS
-
Pharmaceutical and Medicine ManufacturingMedicinal and Botanical ManufacturingPharmaceutical Preparation ManufacturingIn-Vitro Diagnostic Substance ManufacturingBiological Product (except Diagnostic) Manufacturing
- Website
- arraybiopharma.com
- Keywords
- Small molecule drug discovery and development., oncology, biotechnology, melanoma, colorectal cancer.
- HQ
- Boulder, CO
Array Biopharma Inc. Questions
Array Biopharma Inc.'s helpline number is 303.381.6600
Array Biopharma Inc.'s website is arraybiopharma.com
Array Biopharma Inc.'s LinkedIn profile is https://www.linkedin.com/company/array-biopharma
Array Biopharma Inc. has
111 employees.
View email and phone details for 111
employees at Array Biopharma Inc..
Array Biopharma Inc.'s industry is
Pharmaceutical Manufacturing
Array Biopharma Inc.'s top competitors are
Medivation,
Onkure Therapeutics,
Ambrosia Biosciences Inc.,
Pfizer,
Clovis Oncology,
Vertex Pharmaceuticals,
Kite Pharma,
Biohaven,
Hospira,
Seagen.
Array Biopharma Inc.'s support email address is info@arraybiopharma.com
Array Biopharma Inc.'s categories are Pharmaceutical Manufacturing
Array Biopharma Inc.'s founding year is 1998
